ClinicalTrials.Veeva

Menu

TAMBE Japan Post-Marketing Surveillance

W.L. Gore & Associates logo

W.L. Gore & Associates

Status

Not yet enrolling

Conditions

Pararenal Aortic Aneurysm
Thoracoabdominal Aortic Aneurysm

Treatments

Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

Study type

Observational

Funder types

Industry

Identifiers

NCT07147569
JPS 25-02

Details and patient eligibility

About

To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who were attempted to implant the AC
  • Thoracoabdominal aortic aneurysm
  • Pararenal abdominal aortic aneurysm

Exclusion criteria

  • N/A

Trial design

100 participants in 1 patient group

TAMBE
Treatment:
Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems